| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.046 | 0.8 |